https://www.aigom.it/wp-content/uploads/2025/05/ART20.5.png1254841Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-05-20 09:51:122025-05-20 09:51:12DIAGNOSIS AND MANAGEMENT OF INFECTIONS CAUSED BY MULTIDRUG-RESISTANT BACTERIA: GUIDELINE ENDORSED BY ITALIAN SOCIETY OF INFECTION AND TROPICAL DISEASES (SIMIT), THE ITALIAN SOCIETY OF ANTI-INFECTIVE THERAPY (SITA), THE ITALIAN GROUP FOR ANTIMICROBIAL STEWARDSHIP (GISA), THE ITALIAN ASSOCIATION OF CLINICAL MICROBIOLOGIST (AMCLI) AND THE ITALIAN SOCIETY OF MICROBIOLOGY (SIM).
https://www.aigom.it/wp-content/uploads/2025/05/ART13.5.png1273960Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-05-13 10:38:432025-05-13 10:38:43OlympiA: A PHASE 3, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF ADJUVANT OLAPARIB AFTER (NEO)ADJUVANT CHEMOTHERAPY IN PATIENTS WITH GERMLINE BRCA1 AND/OR BRCA2 PATHOGENIC VARIANTS AND HIGH RISK HER2-NEGATIVE PRIMARY BREAST CANCER: LONGER TERM FOLLOW-UP
https://www.aigom.it/wp-content/uploads/2025/05/Screenshot-2025-05-06-102711.png1046752Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-05-06 09:01:132025-05-16 08:17:26NEGRAR DI VALPOLICELLA (VE)-SCUOLA DI METODOLOGIA DELLA RICERCA CLINICA 2025-11° EDIZIONE VENERDI 16-SABATO 17 MAGGIO 2025
https://www.aigom.it/wp-content/uploads/2025/05/ART6MAGGIO.png1284923Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-05-06 08:45:352025-05-06 08:45:35FIRST-LINE MOBOCERTINIB VERSUS PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH EGFR EXON 20 INSERTION-POSITIVE METASTATIC NON-SMALL CELL LUNG CANCER IN THE PHASE III EXCLAIM-2 TRIAL
https://www.aigom.it/wp-content/uploads/2025/04/Screenshot-2025-04-11-100128-2.png428300Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-04-11 08:12:362025-04-11 08:17:3916 GIUGNO 2025-AIGOM LE NOVITA’ DA CHICAGO 2025: L’EVOLUZIONE DELLE CONOSCENZE IN ONCOLOGIA
https://www.aigom.it/wp-content/uploads/2025/04/Screenshot-2025-04-15-160435.png1017750Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-04-08 14:04:572025-04-15 14:20:51NEGRAR DI VALPOLICELLA (VE)-SCUOLA DI METODOLOGIA DELLA RICERCA CLINICA 2025-11° EDIZIONE VENERDI 11-SABATO 12 APRILE 2025
https://www.aigom.it/wp-content/uploads/2025/04/10aprile.png980700Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-04-08 13:59:492025-04-15 14:19:52NEGRAR DI VALPOLICELLA (VE)-SCUOLA DI METODOLOGIA DELLA RICERCA CLINICA 2025-11° EDIZIONE GIOVEDI 10 APRILE 2025
https://www.aigom.it/wp-content/uploads/2025/04/8-APRILE.png1301960Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-04-08 07:56:242025-04-08 07:56:24CAPItello-291 STUDY GROUP. CAPIVASERTIB IN HORMONE RECEPTOR-POSITIVE ADVANCED BREAST CANCER.
https://www.aigom.it/wp-content/uploads/2025/04/1aprile.png15431073Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-04-01 08:32:102025-04-01 08:32:10FRUQUINTINIB VERSUS PLACEBO IN PATIENTS WITH REFRACTORY METASTATIC COLORECTAL CANCER (FRESCO-2): AN INTERNATIONAL, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PHASE 3 STUDY.
https://www.aigom.it/wp-content/uploads/2025/03/2aprile1.png831600Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-03-25 09:40:272025-03-25 09:40:272 APRILE 2025-NUTRIZIONE E ONCOLOGIA: UN DIALOGO TRA RICERCA DI BASE E CLINICA
